Centessa Pharmaceuticals plc 3 SEC Filings

Filed On	Filing
24 Jun 2025	Form 3: Accardi Mario Alberto, President, Orexin Program Holds 216,485 shares of Ordinary Shares
03 Jun 2025	Form 3: Deferiere Raphael, Chief Accounting Officer No securities owned
16 Jan 2025	Form 3: Kanes Stephen, Chief Medical Officer No securities owned
17 Jun 2024	Form 3: Crowley John J, Chief Financial Officer No securities owned
23 Jun 2023	Form 3: Rotman Harris, SVP Regulatory Affairs Holds 33,500 shares of Ordinary Shares
05 Dec 2022	Form 3: Anderson Karen M., Chief People Officer No securities owned
06 Jul 2022	Form 3: Hukkelhoven Mathias, Director No securities owned
15 Mar 2022	Form 3: Shahidi Javad, Chief Medical Officer No securities owned
08 Oct 2021	Form 3: Grainger David J, Chief Innovation Officer Holds 813,756 shares of Ordinary Shares
27 May 2021	Form 3: Gap (Bermuda) Ltd, 10% owner and 9 others
27 May 2021	Form 3: Templeman Thomas, Chief Technology Officer
27 May 2021	Form 3: Index Ventures Life Vi (JERSEY) L.p., 10% owner and 1 other Holds 9,812,368 shares of Ordinary Shares
27 May 2021	Form 3: Saha Saurabh, Director
27 May 2021	Form 3: Goyal Arjun, Director
27 May 2021	Form 3: Stuckley Carol, Director
27 May 2021	Form 3: Kulkarni Samarth, Director
27 May 2021	Form 3: Medicxi Ventures Management (Jersey) Ltd, 10% owner and 7 others Holds 4,398,519 shares of Ordinary Shares
27 May 2021	Form 3: Kantoff Aaron, Director Holds 50,000 shares of Ordinary Shares
27 May 2021	Form 3: Califf Robert, Director
27 May 2021	Form 3: Chao David M, Chief Administrative Officer

Comments